During the past decade, Group Health Cooperative conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 35 clinical trials were completed, i.e. on average, 583.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Group Health Cooperative" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "SWOG Cancer Research Network" with 10 trials sponsored, "Children's Oncology Group" with 8 trials sponsored, "Kaiser Permanente" with 8 trials sponsored and "Alliance for Clinical Trials in Oncology" with 8 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Group Health Cooperative" #1 collaborator was "National Cancer Institute (NCI)" with 28 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 4 trials as a collaborator, "Kaiser Permanente" with 3 trials as a collaborator, "NRG Oncology" with 3 trials as a collaborator and "National Center for Complementary and Integrative Health (NCCIH)" with 3 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Group Health Cooperative" are "Breast Cancer" (5 trials), "Influenza" (5 trials), "Leukemia" (4 trials), "Depression" (3 trials) and "Kidney Cancer" (3 trials). Many other conditions were trialed in "Group Health Cooperative" in a lesser frequency.

Most popular intervention types in "Group Health Cooperative" are "Drug" (52 trials), "Other" (23 trials), "Biological" (20 trials), "Behavioral" (10 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (11 trials), "Paclitaxel" (5 trials), "placebo" (5 trials), "Carboplatin" (4 trials) and "etoposide" (4 trials). Other intervention names were less common.

The vast majority of trials in "Group Health Cooperative" are 58 trials for "All" genders, 12 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Group Health Cooperative". undefined are not yet recruiting, undefined are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 56 completed trials in Group Health Cooperative, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Group Health Cooperative, 5 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".